News
PRISM BioLab, Co. Ltd., a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, announced that it has entered into a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback